Top Stories

Covid-19 vaccine: Pakistan approves Chinese vaccine, cancinobio vaccine will be used emergency

Covid-19 vaccine: Health Minister Faisal Sultan said on Friday that Pakistan has approved China’s Kovid-19 vaccine for emergency use. The vaccine made by Chinese company Cansinobio is the fourth vaccine authorized by the South Asian nation. Earlier, China’s Sinopharm, AstraZeneca and Russia’s Sputnik-V vaccine have also been approved.

Pakistan approved the Kovid-19 vaccine of China

After Mexico, Pakistan is the second country to approve the vaccine of Cansinobio. Mexico has signed an 8 million dose agreement with Cancino. According to the Sultan, Pakistan can get doses ‘in the range of millions of doses’. Cansinobio released the interim results of human tests conducted in several countries including Pakistan last week.

Cancinobio vaccine will be used in emergency

Reuters reported that the vaccine showed 65.7 percent effect in the prevention of symptomatic corona virus cases and the successful rate of preventing serious infections was 90. 98 percent. Let us tell you that Pakistan has talked about importing Kovid-19 vaccine to private companies and has agreed to give a discount on the price range. This decision of the government has given rise to criticism.

Former Health Minister Zafar Mirza told Reuters, “This will lead to inequality in society. This policy of the government is not good because the rich will have the ability to get vaccinated.” Vaccination campaign against Corona virus has been started in the country since January. Allied China has donated 5 lakh doses of Sinoform which is being used as a priority for frontline healthcare workers. However, Pakistan is expected to get 17 million doses under the Kovacs initiative.

World Corona Update: More than 4.13 lakh new cases of corona occurred in 24 hours, more than 12 thousand people lost their lives

Revised resolution passed for Myanmar in United Nations Human Rights Council under pressure from Russia and China


Leave a Reply

Your email address will not be published. Required fields are marked *